Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV

Ebola virus epidemics can be effectively limited by the VSV-EBOV vaccine (Ervebo) due to its rapid protection abilities; however, side effects prevent the broad use of VSV-EBOV as vaccine. Mechanisms explaining the efficient immune activation after single injection with the VSV-EBOV vaccine remain m...

全面介紹

Na minha lista:
書目詳細資料
發表在:Vaccines (Basel)
Main Authors: Friedrich, Sarah-Kim, Schmitz, Rosa, Bergerhausen, Michael, Lang, Judith, Cham, Lamin B., Duhan, Vikas, Häussinger, Dieter, Hardt, Cornelia, Addo, Marylyn, Prinz, Marco, Asano, Kenichi, Lang, Philipp Alexander, Lang, Karl Sebastian
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157200/
https://ncbi.nlm.nih.gov/pubmed/32210083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8010142
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍